Summary
Regeneron Pharmaceuticals, Inc. (REGN) announced on April 3, 2013, the execution of a new, significant operating lease agreement for approximately 297,000 square feet of laboratory and office space. This expansion, located at the Landmark at Eastview in Westchester County, New York, involves the construction of two new buildings by the landlord, with Regeneron undertaking tenant improvements and certain base building work. The lease term extends through June 30, 2029, with multiple options for renewal, indicating a long-term commitment to expanding its operational footprint. This substantial investment in physical infrastructure signals Regeneron's confidence in its future growth and ongoing research and development activities. The expanded facilities will support the company's operations, likely accommodating increased headcount and advanced scientific endeavors. Investors should view this as a positive indicator of the company's strategic planning and its capacity to scale its operations to meet future demands.
Key Highlights
- 1Regeneron signed a new operating lease for approximately 297,000 sq ft of lab and office space.
- 2The new facilities will be located at the Landmark at Eastview in Westchester County, New York.
- 3Two new buildings are to be constructed by the landlord, with Regeneron handling tenant improvements.
- 4The initial lease term is until June 30, 2029, with three 5-year extension options.
- 5This expansion signifies a long-term commitment and investment in the company's growth and R&D capabilities.
- 6The lease commencement date was April 3, 2013.